Active Infection & Immunity Genetics & Molecular Biology

Viral Pathogens

In plain English

AI plain-English summary

A Ugandan research unit is tracking how viruses like HIV, SARS-CoV-2, and Ebola spread, evolve, and cause cancer, while also testing better ways to prevent and treat them. This matters because viral infections remain a major public health challenge, particularly in Africa. HIV still has no vaccine or cure, and emerging threats like Ebola and new coronavirus variants regularly appear. The unit’s close ties to the Uganda Virus Research Institute and the Ministry of Health mean findings can feed directly into national health policy and outbreak response. The research has three strands. First, it will study the epidemiology of HIV, cancer-causing viruses, and emerging infections, including how co-infections and long-term health conditions develop. Second, it will discover new viruses of public health importance and understand how viral diversity influences epidemics and disease severity. Third, it will investigate how oncogenic viruses interact with human hosts to inform cancer prevention and control. Social science research will also examine why people do or do not take up interventions, helping design more effective public health programmes. If successful, this work could improve outbreak surveillance, guide vaccine and treatment strategies, and reduce the burden of virus-linked cancers across East Africa.

View original technical description
Infections caused by viruses remain a major public health challenge especially HIV with no vaccine or a cure and emerging and re-emerging infections like SARS-CoV-2 and Ebola. Our close affiliation to Uganda Virus Research Institute which is one of the few institutes in Africa dedicated to virus research, and the strong links to the Uganda Ministry of Health (MOH) enable the Unit to have impact in addressing these infections. The Viral Pathogen Theme has three focus areas: viral pathogen epidemiology and interventions (VPEI); viral pathogen discovery, diversity and impact on epidemic and disease outcome (VPDD); and oncogenic virus immunovirology (OVI). Our aims and key objectives for each of the above focus areas will include: 1) VPEI: We will undertake research on the epidemiology & prevention of HIV, oncogenic and emerging/re-emerging viral infections, associated co-infections, and studies to improve long-term health conditions. 2) VPDD: We will contribute to the discovery of emerging viruses of public health importance and understand how viral diversity affects epidemics and disease outcome 3) OVI: We will also study oncogenic viruses and their host interactions in order to contribute to cancer prevention and control In the areas of VPEI and OVI, our work will include rigorous social science research to understand the social determinants of disease, to design appropriate interventions, and to study factors that influence uptake of interventions.

View the original record at the funder ↗

Researchers

Pontiano Kaleebu (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Arthropod-borne infections
Virus Genomics for Outbreak Response (ViGOR) in Central/East Africa
Enhanced Virus Surveillance and Intervention Strategies for Health Preparedness in Uganda
Makerere University UVRI Centre of Excellence for Infection & Immunity Research and Training (MUII-plus)
Structural Studies on Viruses, Viral Proteins and Cell Interactions

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.